Jon P. Miller - Concepedia

Author

Jon P. Miller

Also Known As

J P Miller, J Paul Miller, J. P. MILLER, J. P. Miller, J.P. MILLER, J.P. Miller, Jolie Miller, Jon P Miller, Jon P. MILLER, Jon P. Miller

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

SRI International Menlo School Saint Louis University University of Bergen Vanderbilt University

About

Jon P. Miller is an author at SRI International specializing in biochemistry, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	18	26	1.2K
2	Medicine	17	22	959
3	Natural Sciences	17	25	1.1K
4	Engineering	5	5	192
5	Health Sciences	3	3	235

Jon P. Miller

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Comparison of the two classes of binding sites (A and B) of type I and type II cyclic‐AMP‐dependent protein kinases by using cyclic nucleotide analogs Dagfinn ØGRIED, Roald Ekanger, Robert H. Suva, European Journal of Biochemistry	1989	146
Studies of cGMP analog specificity and function of the two intrasubunit binding sites of cGMP-dependent protein kinase. Jackie D. Corbin, Jon P. Miller, Robert H. Suva, Journal of Biological Chemistry Bioorganic ChemistryCgmp BindingMolecular BiologySignal RecognitionChemical Biology	1986	136
Activation of protein kinase isozymes by cyclic nucleotide analogs used singly or in combination Dagfinn Øgreid, Roald Ekanger, Robert H. Suva, European Journal of Biochemistry	1985	113
Synthesis and biochemical studies of various 8-substituted derivatives of guanosine cyclic-3',5' phosphate, inosine cyclic-3',5' phosphate, and xanthosine cyclic-3',5' phosphate Jon P. Miller, Kay H. Boswell, Kei Muneyama, Biochemistry Various 8-Substituted DerivativesDerivative (Chemistry)DerivativesBioorganic ChemistryBiochemistry	1973	105
Purine analog inhibitors of xanthine oxidase ‐ structure activity relationships and proposed binding of the molybdenum cofactor Roland K. Robins, Ganapathi R. Revankar, Darrell E. O'Brien, Journal of Heterocyclic Chemistry New PhenylMolybdenum CofactorPharmacotherapyChemical BiologyPharmaceutical Chemistry	1985	104
THE RELATIONSHIP BETWEEN THE METABOLISM OF RIBAVIRIN AND ITS PROPOSED MECHANISM OF ACTION Jon P. Miller, Linda J Kigwana, David Streeter, Annals of the New York Academy of Sciences Energy MetabolismBiochemistryMedicinePhysiologyCatabolism	1977	87
Induction of hepatic tyrosine aminotransferase in vivo by derivatives of cyclic adenosine 3':5'-monophosphate Jon P. Miller, Andreas Beck, Lionel N. Simon, Journal of Biological Chemistry Non-induced EnzymeHepatic Tyrosine AminotransferaseBiosynthesisSignal TransductionHepatology	1975	75
Synthesis and biological activity of some 2' derivatives of adenosine 3',5'-cyclic phosphate Jon P. Miller, Dennis A. Shuman, Mieka B. Scholten, Biochemistry Altmetric Attention ScoreHeterocycle ChemistryChemical BiologyPharmaceutical ChemistryChemical Derivative	1973	73
Analogs of cyclic AMP that elicit the biochemically defined conformational change in catabolite gene activator protein (CAP) but do not stimulate binding to DNA Richard H. Ebright, Stuart F.J. Le Grice, Jon P. Miller, Journal of Molecular Biology Signal TransductionProtein AssemblyBiochemistryNatural SciencesMolecular Biology	1985	70
Effect of Cyclic Nucleotide Analogs on Intrachain Site 1 of Protein Kinase Isozymes Jackie D. Corbin, S. R. Rannels, David A. Flockhart, European Journal of Biochemistry	1982	65

Page 1